Cargando…
Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates
The use of immune reconstitution therapies (IRT) in patients with relapsing-remitting multiple sclerosis (RRMS) is associated with a prolonged period of freedom from relapses in the absence of continuously applied therapy. Cladribine tablets is a disease-modifying treatment (DMT) indicated for highl...
Autores principales: | Inshasi, Jihad S., Alfahad, Sarmed, Alsaadi, Taoufik, Hassan, Ali, Zein, Tayseer, Mifsud, Victoria Ann, Nouri, Suzan Ibrahim, Shakra, Mustafa, Shatila, Ahmed Osman, Szolics, Miklos, Thakre, Mona, Kumar, Ajit, Boshra, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062252/ https://www.ncbi.nlm.nih.gov/pubmed/33891277 http://dx.doi.org/10.1007/s40120-021-00243-6 |
Ejemplares similares
-
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study
por: Inshasi, Jihad, et al.
Publicado: (2023) -
Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region
por: Inshasi, Jihad, et al.
Publicado: (2022) -
The use of alemtuzumab in patients with relapsing-remitting multiple
sclerosis: the Gulf perspective
por: Alroughani, Raed, et al.
Publicado: (2020) -
Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region
por: Alroughani, Raed, et al.
Publicado: (2020) -
Depression and anxiety as determinants of health-related quality of life in patients with multiple sclerosis - United Arab Emirates
por: Alsaadi, Taoufik, et al.
Publicado: (2017)